Sol-Gel Technologies Current Ratio 2016-2018 | SLGL

Sol-Gel Technologies current ratio from 2016 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Sol-Gel Technologies Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.08B $0.01B 15.96
2018-06-30 $0.08B $0.00B 20.77
2018-03-31 $0.09B $0.00B 43.22
2017-12-31 $0.01B $0.07B 0.16
2017-09-30 $0.02B $0.07B 0.25
2017-06-30 $0.00B $0.00B 0.00
2016-12-31 $0.01B $0.04B 0.20
2015-12-31 $0.01B $0.02B 0.32
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.118B $0.000B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.409B 8.83
Teva Pharmaceutical Industries (TEVA) Israel $19.738B 6.05
Mylan (MYL) United Kingdom $15.753B 6.49
Bausch Health Cos (BHC) Canada $8.275B 5.99
Dr Reddy's Laboratories (RDY) India $6.267B 24.99
Supernus Pharmaceuticals (SUPN) United States $1.909B 18.08
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.730B 2.88
Amphastar Pharmaceuticals (AMPH) United States $1.014B 109.95
Homology Medicines (FIXX) United States $0.937B 0.00
Assembly Biosciences (ASMB) United States $0.634B 0.00
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.511B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.386B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.273B 0.00
Teligent (TLGT) United States $0.086B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.085B 0.00
Aevi Genomic Medicine (GNMX) United States $0.077B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Acasti Pharma (ACST) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Agile Therapeutics (AGRX) United States $0.028B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.005B 0.00